Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

3,6-bis(2-piperidinoethoxy)acridine trihydrochloride

Known as: 3,6-bis-(2-piperidinoethoxyl)acridine trihydrochloride, Acridine, 3,6-bis(2-(1-piperidinyl)ethoxy) trihydrochloride 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Small molecules interfering with Rac1 activation are considered as potential drugs and are already studied in animal models. A… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Because delayed gastric emptying and impaired gastric accommodation are regarded as pathophysiological mechanisms underlying… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2007
2007
3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) is a novel compound with… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2007
2007
Ovariectomized Fischer (CDF-344) rats, with bilateral cannulae in the mediobasal hypothalamus (MBH) near the ventromedial nucleus… Expand
Is this relevant?
1991
1991
CL 246,738 is a low molecular weight, synthetic immunomodulator. The present study was done to determine the interaction among… Expand
Is this relevant?
1990
1990
CL 246,738 is a synthetic heterocyclic of the acridine class that has immunomodulating, interferon (IFN)-inducing, and antitumor… Expand
Is this relevant?
1989
1989
An interferon (IFN) inducer and immunomodulator, CL246,738 [3,6-bis(2-piperidinoethoxy)acridine trihydrochloride], protected mice… Expand
Is this relevant?
1986
1986
An effort has been made to determine the mechanism by which the immunomodulator 3,6-bis(2-piperidinoethoxy)acridine… Expand
Is this relevant?
1985
1985
3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738) has been investigated for its immunomodulatory effect on murine… Expand
Is this relevant?